Clinical Trials

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell

NCT03543969 2026-02-05

Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma

14 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Melanoma, Skin Neoplasms

NCT07389525 2026-02-05

Immune Checkpoint Inhibitor (ICI)-Drug-Drug Interaction (DDI) Study

80 enrolled

DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

NCT06472661 2025-11-20

Mel 70

11 enrolled

Melanoma

NCT05279027 2025-09-19

Zr89 + PET Companion Trial

Melanoma

NCT02652455 2025-08-19

Combining PD-1 Blockade, CD137 Agonism and Adoptive Cell Therapy for Metastatic Melanoma

11 enrolled

Melanoma, Skin Neoplasms

NCT04581382 2025-07-10

Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma

18 enrolled

Melanoma

NCT05498792 2025-04-04

Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma

12 enrolled

Phase EARLY_PHASE1 Not yet recruiting

Melanoma

NCT06756295 2025-03-12

FAST-CR

154 enrolled

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT03784625 2025-02-13

MELRIV-1

10 enrolled

Melanoma

NCT04752267 2024-05-24

18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain Metastases

BreastCNSDermatologicGastrointestinalGenitourinaryThoracic

10 enrolled

Brain Neoplasms, Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Glioma, Lung Neoplasms, Melanoma

NCT03893019 2024-05-16

MB-CART20.1 Melanoma

9 enrolled

Melanoma

NCT04541108 2024-04-18

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

DermatologicHead & NeckLymphoidSarcoma

15 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT06212388 2024-01-25

Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma

Phase EARLY_PHASE1 Not yet recruiting

10 enrolled

Melanoma

NCT04663126 2023-12-13

Tilmanocept

5 enrolled

Melanoma

NCT02382549 2023-12-12

Mel61

8 enrolled

Melanoma

NCT05961111 2023-07-27

A Clinical Study on Oncolytic Virus Injection (R130 OV) for the Treatment of Advanced Solid Tumors

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Brain Neoplasms, Breast Neoplasms, Carcinoma, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Sarcoma

NCT03060356 2023-06-22

Autologous T Cells Expressing MET scFv CAR (RNA CART-cMET)

77 enrolled

BreastDermatologic

Breast Neoplasms, Melanoma

NCT02591654 2022-12-30

MPAK

Melanoma, Neoplasm Metastasis

NCT02013492 2022-12-06

Propranolol Hydrochloride in Treating Patients With Locally Recurrent or Metastatic Solid Tumors That Cannot Be Removed By Surgery

BreastDermatologicGastrointestinalGynecologic

1 enrolled

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Hepatocellular, Melanoma, Breast Neoplasms, Male

NCT00962845 2022-09-07

Hydroxychloroquine in Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Melanoma

NCT03655756 2022-08-08

pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma

7 enrolled 9 charts

Melanoma

NCT03526185 2022-07-25

A Pilot Study Using Short-Term Cultured Anti-Tumor Autologous Lymphocytes

Phase EARLY_PHASE1 Withdrawn

Melanoma

NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT05180851 2022-02-01

YSCH-01

Phase EARLY_PHASE1 Unknown

28 enrolled

BreastDermatologicGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Ovarian Neoplasms, Virus Diseases

NCT04223648 2021-11-22

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Phase EARLY_PHASE1 Withdrawn

Phase EARLY_PHASE1 Withdrawn

Melanoma

NCT04285749 2020-07-27

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

Melanoma

NCT03338777 2020-02-25

IGTM-101

4 enrolled

Melanoma

NCT02320305 2020-01-14

MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery

23 enrolled

Phase EARLY_PHASE1 Unknown

Melanoma

NCT03649529 2019-12-06

Treatment of Malignant Melanoma With GPA-TriMAR-T Cell Therapy

Melanoma

NCT02316795 2019-09-24

Fluorescence Imaging in Sentinel Lymph Node Biopsy for Breast Cancer and Melanoma

BreastDermatologic

Breast Neoplasms, Melanoma

NCT01789827 2019-08-05

Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy

5 enrolled

Melanoma

NCT03454243 2019-04-25

TITAN

DermatologicGenitourinaryLymphoidThoracic

1 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Carcinoma, Transitional Cell, Hodgkin Disease, Melanoma

NCT01666353 2019-02-08

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

DermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma

NCT00499733 2019-01-18

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckLymphoidSarcomaThoracic

19 enrolled

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Chondrosarcoma, Colonic Neoplasms, Carcinoma, Hepatocellular, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Sarcoma, Osteosarcoma, Tongue Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Breast Neoplasms, Male, Small Cell Lung Carcinoma, Intraocular Lymphoma

NCT01748747 2018-10-09

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

30 enrolled

Melanoma

NCT01568996 2018-01-09

Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions

17 enrolled

Dysplastic Nevus Syndrome, Melanoma

NCT00972933 2017-12-07

Immunogenicity and Biomarker Analysis of Neoadjuvant Ipilimumab for Melanoma

59 enrolled

Melanoma

NCT00871533 2017-08-04

Pilot Study of IFN α2b for Melanoma Patients

50 enrolled

Melanoma

NCT01209676 2016-11-15

IMCgp100 in Advanced Unresectable Melanoma

1 enrolled

Melanoma

NCT01425749 2016-04-04

Mel55

25 enrolled 12 charts

Melanoma, Skin Diseases, Skin Neoplasms

NCT02442466 2015-05-20

Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma

5 enrolled

Melanoma

NCT00276835 2015-04-10

Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer

DermatologicGenitourinary

15 enrolled

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma

NCT00470379 2014-10-31

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

30 enrolled

Phase EARLY_PHASE1 Unknown

Melanoma

NCT01620749 2012-06-15

MEL050

12 enrolled